Democrats Question Dr. Oz's Medicare Privatization Stance and Financial Ties

Lawmakers express concerns about Trump's CMS nominee's advocacy for Medicare Advantage and potential conflicts of interest.

Senator Elizabeth Warren and five other Democrats have sent a letter to Dr. Mehmet Oz questioning his past support for replacing Traditional Medicare with Medicare Advantage plans.
Oz, President-elect Trump's pick to lead the Centers for Medicare and Medicaid Services (CMS), co-authored a 2020 op-ed advocating for 'Medicare Advantage for All.'
Lawmakers raised concerns about Oz's financial ties, including over $550,000 in UnitedHealth stock, a company currently under investigation for Medicare fraud and antitrust violations.
Democrats highlighted findings that Medicare Advantage plans are projected to overcharge the government by $83 billion in 2024 compared to Traditional Medicare.
Oz is expected to face scrutiny during his Senate confirmation hearing, with Democrats pressing for answers on his policy positions and potential conflicts of interest.